By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Immage Biotherapeutics Corp.

Immage Biotherapeutics Corp. (IMMG)

OTC Currency in USD
$0.00
$0.00
0.00%
Last Update: 22 Aug 2025, 20:00
$15.18K
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.00 - $0.00
52 Week Range

IMMG Stock Price Chart

Explore Immage Biotherapeutics Corp. interactive price chart. Choose custom timeframes to analyze IMMG price movements and trends.

IMMG Company Profile

Discover essential business fundamentals and corporate details for Immage Biotherapeutics Corp. (IMMG) to support your stock research and investment decisions.

Sector

Financial Services

Industry

Financial - Conglomerates

IPO Date

2 Dec 2022

Employees

3.00

CEO

Zhi Cong Mou

Description

Immage Biotherapeutics Corp. does not have significant business operations. Previously, it was engaged in developing novel immunotherapy biologics to treat various cancers in the United States. The company was formerly known as Epicure Charcoal, Inc. and changed its name to Immage Biotherapeutics Corp. in June 2015. The company was founded in 2012 and is headquartered in Bethesda, Maryland. Immage Biotherapeutics Corp. is a subsidiary of Coventry International Limited.

IMMG Financial Timeline

Browse a chronological timeline of Immage Biotherapeutics Corp. corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

IMMG Stock Performance

Access detailed IMMG performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run